← Leaderboards
Wilnelly Martinez-Ortiz
New York University School Of Medicine
$163,379
Attributed
$163,379
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.3K · FY2014–18$50K$37.5K$25K$12.5K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$163,379 · 1
By mechanism
F31$163,379 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Jill P Buyon$29,367,681
- Chuanshu Huang$11,325,976
- Peter Izmirly$3,742,276
- Ira Jay Goldberg$42,989,404
- John A Dodson$11,071,981
Others in their field
Top investigators on “Epitopes”
- Lawrence Corey · Fred Hutchinson Cancer Center$261,200,380
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$255,239,983
- Dennis R. Burton · Scripps Research Institute$109,374,382
- Barton F Haynes · Duke University$108,968,244
- Alessandro Sette · La Jolla Institute For Immunology$86,747,756
- Dan H. Barouch · Fred Hutchinson Cancer Center$81,679,346
Research focus
EpitopesEnvironmentAmino AcidsEffective TherapyEnrollmentApoptoticAutoantibodiesAutoimmune DiseasesDesignAffectAntibodiesBinding SitesBloodBlood ScreeningB-LymphocytesBone MarrowCalciumCardiac MyocytesChildAutoimmunityCohortComplexAntigensFamily
Grant awards (5)
Characterizing the Polyclonal Scope of Pathogenic anti-Ro Antibodies$28,747
F31 · FY2018 · HL · contact PI
Characterizing the Polyclonal Scope of Pathogenic anti-Ro Antibodies$34,348
F31 · FY2017 · HL · contact PI
Characterizing the Polyclonal Scope of Pathogenic anti-Ro Antibodies$33,880
F31 · FY2016 · HL · contact PI
Characterizing the Polyclonal Scope of Pathogenic anti-Ro Antibodies$33,424
F31 · FY2015 · HL · contact PI
Characterizing the Polyclonal Scope of Pathogenic anti-Ro Antibodies$32,980
F31 · FY2014 · HL · contact PI